Space-Based Solar Power
Discover companies pioneering the capture of solar energy from orbit. These carefully selected stocks represent leaders in orbital solar farm technology and wireless energy transmission, working toward a future of continuous clean power beamed directly to Earth.
Your Basket's Financial Footprint
Market capitalisation breakdown for the Space-Based Solar Power basket provided by the user.
- Large-cap dominance suggests generally lower risk, less volatility, and closer tracking of broad market performance.
- Suitable as a core holding in a diversified portfolio rather than a speculative trade.
- Less likely to produce explosive short-term gains; oriented toward steady, long-term appreciation.
WATT: $12.10M
LMT: $113.27B
FSLR: $24.33B
- Other
About This Group of Stocks
Our Expert Thinking
This collection focuses on a revolutionary approach to renewable energy: harvesting the sun's power from space where solar radiation is uninterrupted by weather, atmosphere, or nightfall. These companies are developing the technology to beam this continuous energy back to Earth, potentially solving the intermittency problem that plagues traditional renewables.
What You Need to Know
This is a high-risk, speculative investment theme with long-term potential. The technology is still emerging, but falling launch costs and increasing global demand for reliable clean energy create significant momentum. Companies in this group span aerospace, satellite technology, photovoltaics, and wireless power transmission sectors.
Why These Stocks
Each company was selected for its specific contribution to the space-based solar power ecosystem. From manufacturers of specialized solar panels and satellite systems to firms pioneering wireless energy transmission, these companies represent the full value chain needed to make orbital solar farms a reality.
Why You'll Want to Watch These Stocks
The Ultimate Frontier Market
Space-based solar could be worth trillions as a market. Getting in early on companies developing this technology might mean positioning yourself at the ground floor of what could become humanity's largest power source.
Energy's Holy Grail
These companies are chasing what energy experts call the ultimate solution: continuous, abundant, clean power without weather dependencies or land use conflicts. If they succeed, they could disrupt the entire global energy sector.
Tomorrow's Tech Today
While full-scale space solar might be years away, these companies are developing valuable technologies with near-term applications in satellite power, communications, and aerospace that could drive growth well before the first power beam.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Global Infrastructure Partners: UAE Exposure Risks
The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.
UAE Infrastructure Global Suppliers Breakdown
As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.
Antiviral M&A Wave: Biotech Opportunities in 2025
Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.